{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:07:52Z","timestamp":1773288472698,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1676,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R43AR056559-01"],"award-info":[{"award-number":["1R43AR056559-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["FDA OOPD R01-FD-003553-01"],"award-info":[{"award-number":["FDA OOPD R01-FD-003553-01"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010637","name":"Huntsman Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/jid.2010.372","type":"journal-article","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T12:30:48Z","timestamp":1293712248000},"page":"1029-1036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of Quantitative Molecular Clinical End Points for siRNA Clinical Trials"],"prefix":"10.1016","volume":"131","author":[{"given":"Robyn P.","family":"Hickerson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sancy A.","family":"Leachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana N.","family":"Pho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Gonzalez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances J.D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H. Irwin","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Contag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Leake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard M.","family":"Milstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger L.","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2010.372_bb0010","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/sj.jid.5700412","article-title":"An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting","volume":"126","author":"Benson","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.372_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1535-6108(02)00122-8","article-title":"Stable suppression of tumorigenicity by virus-mediated RNA interference","volume":"2","author":"Brummelkamp","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1038\/jid.2010.372_bb0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1038\/jid.2010.372_bb0025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1038\/jid.2010.372_bb0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrd2310","article-title":"Interfering with disease: a progress report on siRNA-based therapeutics","volume":"6","author":"de Fougerolles","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/jid.2010.372_bb0035","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2010.372_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1474-9728.2003.00054.x","article-title":"Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis","volume":"2","author":"Ding","year":"2003","journal-title":"Aging Cell"},{"key":"10.1038\/jid.2010.372_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2006.07.007","article-title":"Knocking down disease with siRNAs","volume":"126","author":"Dykxhoorn","year":"2006","journal-title":"Cell"},{"key":"10.1038\/jid.2010.372_bb0050","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1073\/pnas.0601309103","article-title":"Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism","volume":"103","author":"Dykxhoorn","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2010.372_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1038\/jid.2010.372_bb0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/jid.2010.372_bb0065","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/gt.2009.62","article-title":"siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model","volume":"16","author":"Gonzalez-Gonzalez","year":"2009","journal-title":"Gene Therapy"},{"key":"10.1038\/jid.2010.372_bb0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/jvi.65.1.473-478.1991","article-title":"The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells","volume":"65","author":"Halbert","year":"1991","journal-title":"J Virol"},{"key":"10.1038\/jid.2010.372_bb0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/hum.2008.007","article-title":"The business of RNAi therapeutics","volume":"19","author":"Haussecker","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2010.372_bb0080","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.gt.3302855","article-title":"Gene therapy progress and prospects: the skin--easily accessible, but still far away","volume":"13","author":"Hengge","year":"2006","journal-title":"Gene Therapy"},{"key":"10.1038\/jid.2010.372_bb0085","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5701060","article-title":"Single nucleotide-specific siRNA targeting in a dominant-negative skin model","volume":"128","author":"Hickerson","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.372_bb0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/oli.2008.0149","article-title":"Stability study of unmodified siRNA and relevance to clinical use","volume":"18","author":"Hickerson","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1038\/jid.2010.372_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","article-title":"Strategies for silencing human disease using RNA interference","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1038\/jid.2010.372_bb0100","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1096\/fj.08-110890","article-title":"Allele-specific silencing of the dominant disease allele in sialuria by RNA interference","volume":"22","author":"Klootwijk","year":"2008","journal-title":"FASEB J"},{"key":"10.1038\/jid.2010.372_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.1643","article-title":"Keratins and skin disorders","volume":"204","author":"Lane","year":"2004","journal-title":"J Pathol"},{"key":"10.1038\/jid.2010.372_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.04.003","article-title":"Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita","volume":"51","author":"Leachman","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2010.372_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2010.372_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1087-0024.2005.10202.x","article-title":"Clinical and pathological features of pachyonychia congenita","volume":"10","author":"Leachman","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2010.372_bb0125","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1073\/pnas.90.8.3197","article-title":"Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex","volume":"90","author":"Letai","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2010.372_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 years experience of the dermatology life quality index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2010.372_bb0135","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2010.372_bb0140","first-page":"158","article-title":"RNAi therapeutics: an update on delivery","volume":"10","author":"Nguyen","year":"2008","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/jid.2010.372_bb0145","first-page":"217","article-title":"Delivering silence: advancements in developing siRNA therapeutics","volume":"11","author":"Novobrantseva","year":"2008","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1038\/jid.2010.372_bb0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"10.1038\/jid.2010.372_bb0155","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1073\/pnas.89.2.594","article-title":"Methotrexate induces differentiation of human keratinocytes","volume":"89","author":"Schwartz","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2010.372_bb0160","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA that distinguish between genes that differ by a single nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1038\/jid.2010.372_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00128071-200304050-00005","article-title":"The molecular genetics of keratin disorders","volume":"4","author":"Smith","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1038\/jid.2010.372_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.jid.5701040","article-title":"Development of therapeutic siRNAs for pachyonychia congenita","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.372_bb0175","series-title":"GeneReviews","article-title":"Pachyonychia congenita","author":"Smith","year":"2006"},{"key":"10.1038\/jid.2010.372_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1087-0024.2005.10204.x","article-title":"The genetic basis of pachyonychia congenita","volume":"10","author":"Smith","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2010.372_bb0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1038\/jid.2010.372_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0625.2006.00534.x","article-title":"Rapid, high-quality and epidermal-specific isolation of RNA from human skin","volume":"16","author":"Trost","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2010.372_bb0195","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/sj.jid.5700891","article-title":"Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model","volume":"127","author":"Wang","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.372_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/jid.2010.372_bb0205","series-title":"J Invest Dermatol","article-title":"A large mutational study in pachyonychia congenita","author":"Wilson","year":"2009"},{"key":"10.1038\/jid.2010.372_bb0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1083\/jcb.200305032","article-title":"Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair","volume":"163","author":"Wong","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2010.372_bb0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.0022-202X.2004.22729.x","article-title":"Use of RT-PCR and DNA microarrays to characterize RNA recovered by non-invasive tape harvesting of normal and inflamed skin","volume":"123","author":"Wong","year":"2004","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15352568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15352568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:37:06Z","timestamp":1743961026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15352568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0022202X15352568"],"URL":"https:\/\/doi.org\/10.1038\/jid.2010.372","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Quantitative Molecular Clinical End Points for siRNA Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2010.372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}